Skip to main content
Fig. 2 | Cardiovascular Diabetology

Fig. 2

From: Effect of tofogliflozin on arterial stiffness in patients with type 2 diabetes: prespecified sub-analysis of the prospective, randomized, open-label, parallel-group comparative UTOPIA trial

Fig. 2

Delta change in baPWV from the baseline to weeks 52 and 104. Data are presented as the mean ± SE. Comparisons of baPWV values during treatment with those at baseline were performed using a one-sample t-test. *p < 0.05, #p < 0.01, §p < 0.001. Differences in delta change in baPWV from baseline to weeks 52 and 104 between the groups at each point (treatment effect) were analyzed using Student’s t-test. baPWV, brachial-ankle pulse wave velocity; TOF, tofogliflozin treatment group; CON, conventional treatment group

Back to article page

Cardiovascular Diabetology

ISSN: 1475-2840